ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 355644 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 355644; 2) Community: the network communities that were significantly associated with the response to NSC 355644; 3) Molecule: the relationships between components within communities and NSC 355644; 4) MDR: the compounds that were significantly associated with the NSC 355644.

NSC Compound Enrichment Correlation
NSC 696073 Null 0.00503396694999381 0.210249
NSC 741459 (11aS)-8-(3-[(11aS)-2,2-difluoro-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypropoxy)-2,2-difluoro-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4 0.00503396694999381 0.69952073
NSC 756375 GW811761X 0.00503396694999381 0.1209171
NSC 716688 Null 0.00550789647802199 0.25054745
NSC 691250 Null 0.00559873245069072 0.60123692
NSC 656902 Null 0.00578566967432527 0.33395836
NSC 374028 Camptothecin Derivative 0.00645628049634952 0.61955313
NSC 627168 2-[(3-N',N'-Dimethylamino)propyl]-9-methoxy-5-nitro-[6H]- pyrazolo[3,4,5-kl]acridine, free base 0.00645628049634952 0.22157215
NSC 659948 7-O-(2,3,6-Trideoxy-2-fluoro-.alpha.-L-talo-hexopyranosyl)-4-demethoxydaunomycinone 0.00645628049634952 0.70748343
NSC 665524 Null 0.00645628049634952 0.054524578
Total:45  Current:6    [First] [Prev] [Next] [Last]